SenesTech, Inc. (SNES) Stock: Is This Biotech Stock Worth Your Attention?


SenesTech, Inc. (SNES) is gaining in the market today. The stock, focused in the biotech industry, is currently priced at $1.15 after a move up of 6.48% so far today. As it relates to biotech stocks, there are several aspects that have the ability to cause price movement in the market. One of the most common is news. Here are the recent stories relating to SNES:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-27-19 09:00AM ContraPest® Deployment in Los Angeles, CA
Aug-20-19 12:04PM What Kind Of Shareholder Appears On The SenesTech, Inc.’s (NASDAQ:SNES) Shareholder Register?
Aug-13-19 04:05PM SenesTech Announces Second Quarter 2019 Financial and Operational Results
07:50AM SenesTech’s Earnings Outlook
Aug-05-19 04:05PM 7 Stocks the Insiders Are Buying on Sale

Nonetheless, any time investors are making a decision to invest, prospective investors should take a look at far more than news, this is especially the case in the generally speculative biotech sector. Here’s what’s happening in regard to SenesTech, Inc..

The Performance That We’ve Seen From SNES

While a gain in a single session, like the move that we’re seeing from SenesTech, Inc. may cause excitement in some investors, that by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It is generally a good idea to look into trends experienced by the stock beyond a single trading day. When it comes to SNES, below are the returns that we have seen:

  • Past 5 Sessions – In the past five trading sessions, SNES has generated a change in value that amounts to -0.43%.
  • Past Month – The return from SenesTech, Inc. in the past month has been -26.28%.
  • Past 3 Months – Throughout the past three months, the company has generated a ROI that comes to -21.77%
  • Past Six Months – Throughout the last 6 months, we’ve seen a change that equates to 25.16% from the stock.
  • YTD – Since the close of last year SNES has produced a return of 96.51%.
  • Annually – Lastly, in the last year, investors have seen performance that works out to 28.51% out of SNES. Throughout this period, the stock has traded at a high of -41.03% and a low price of 109.09%.

Ratios To Pay Attention To

Digging into a few key ratios having to do with a company generally gives prospective traders a view of how dangerous and/or rewarding a an investment option may be. Below are a few of the most important ratios to think about when looking at SNES.

Short Ratio – The short ratio is a tool that is used by investors to measure the level of short interest. The higher this ratio, the more investors have a belief that the price of the stock is headed for declines. In general, biotech stocks tend to have a higher short ratio. However, we tend to see a lot of short squeezes in the industry. Nonetheless, in relation to SenesTech, Inc., it’s short ratio comes to 5.37.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Essentially, they measure whether or not a company can pay its debts when they mature with only current assets or quick assets. Because many biotech companies are heavily reliant on continued support from investors, these ratios can be upsetting. Nonetheless, several better companies in the biotechnology space do have strong current and quick ratios. In terms of SNES, the quick and current ratios total up to 2.60 and 3.70 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the book value of assets that are owned by the company. In the case of SenesTech, Inc., the book to share value ratio equates to 0.16.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the value of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotech stock, this is an important ratio to look into. In this case, the cash to share value is 0.

How Analysts Feel About SenesTech, Inc.

While it’s rarely a smart idea to blindly follow the thoughts of analysts, it is a smart idea to use their opinions in order to validate your own thoughts before making an investment decision in the biotech sector. Here are the most recent moves that we have seen from analysts when it comes to SNES.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in SNES, here’s what we’re seeing:

Institutions own 7.60% of the company. Institutional interest has moved by 4.24% over the past three months. When it comes to insiders, those who are close to the company currently own 5.30% percent of SNES shares. Institutions have seen ownership changes of an accumulative 67.72% over the last three months.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 28.80M shares of SenesTech, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SNES has a float of 25.77M.

I also like to take a look at the short percent. Think about it, when a high portion of the float available for trading is shorted, the overall opinion among investors is that the equity is going to lose value. In regard to SNES, the short percentage of the float totals up to 4.23%. In general, concerning short percent of the float would be considered to be anything over 40%. However, I have seen that a short ratio over 26% is probably going to be a risky play.

Financial Performance

What have ween seen from SNES in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts are expecting that SenesTech, Inc. will come up with EPS in the amount of -0.29, with -0.09 being announced in the earnings announcement for the current quarter. Although this data isn’t earnings driven, since we’re talking about Wall St. analysts, the stock is currently graded as a 2.00 when rated on a scale from 1 to 5 on which 1 is the poorest possible Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – Throughout the last half decade, SenesTech, Inc. has generated a change in sales that works out to be 0. Earnings per share through the period have generated movement in the amount of 0.
  • Q/Q – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in today’s society, the company has created a change in earnings in the amount of 62.20%. The company has also experienced movement with regard to revenue that adds up to -33.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. Nonetheless, I was created by a human and human beings play a crucial role in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I learn much faster when I have the help of a teacher. If you would to teach me something, I would love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at something? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here